BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10221518)

  • 1. Expression of receptor tyrosine kinase HTK (hepatoma transmembrane kinase) and HTK ligand by human leukemia-lymphoma cell lines.
    Steube KG; Meyer C; Habig S; Uphoff CC; Drexler HG
    Leuk Lymphoma; 1999 Apr; 33(3-4):371-6. PubMed ID: 10221518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells.
    Sakano S; Serizawa R; Inada T; Iwama A; Itoh A; Kato C; Shimizu Y; Shinkai F; Shimizu R; Kondo S; Ohno M; Suda T
    Oncogene; 1996 Aug; 13(4):813-22. PubMed ID: 8761303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tie receptor tyrosine kinase in human leukemia cell lines.
    Bredoux C; Uphoff CC; Drexler HG
    Leuk Res; 1997 Jul; 21(7):595-601. PubMed ID: 9301679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk.
    Bennett BD; Zeigler FC; Gu Q; Fendly B; Goddard AD; Gillett N; Matthews W
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1866-70. PubMed ID: 7534404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective expression of the receptor tyrosine kinase, HTK, on human erythroid progenitor cells.
    Inada T; Iwama A; Sakano S; Ohno M; Sawada K; Suda T
    Blood; 1997 Apr; 89(8):2757-65. PubMed ID: 9108393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of HTK, a novel transmembrane tyrosine kinase of the EPH subfamily.
    Bennett BD; Wang Z; Kuang WJ; Wang A; Groopman JE; Goeddel DV; Scadden DT
    J Biol Chem; 1994 May; 269(19):14211-8. PubMed ID: 8188704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of ephrin-Bs and their receptors in colon carcinoma.
    Liu W; Ahmad SA; Jung YD; Reinmuth N; Fan F; Bucana CD; Ellis LM
    Cancer; 2002 Feb; 94(4):934-9. PubMed ID: 11920461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of EPH-ephrin signaling on the growth of human leukemia cells.
    Takahashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2014 Jun; 34(6):2913-8. PubMed ID: 24922654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.
    Meierhoff G; Dehmel U; Gruss HJ; Rosnet O; Birnbaum D; Quentmeier H; Dirks W; Drexler HG
    Leukemia; 1995 Aug; 9(8):1368-72. PubMed ID: 7643626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of the ufo/axl oncogene in human leukemia-lymphoma cell lines.
    Challier C; Uphoff CC; Janssen JW; Drexler HG
    Leukemia; 1996 May; 10(5):781-7. PubMed ID: 8656672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands.
    Holland SJ; Gale NW; Mbamalu G; Yancopoulos GD; Henkemeyer M; Pawson T
    Nature; 1996 Oct; 383(6602):722-5. PubMed ID: 8878483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tie receptor tyrosine kinase in leukemia cell lines.
    Armstrong E; Korhonen J; Silvennoinen O; Cleveland JL; Lieberman MA; Alitalo R
    Leukemia; 1993 Oct; 7(10):1585-91. PubMed ID: 8412320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of receptor protein tyrosine kinase tif is regulated during leukemia cell differentiation.
    Dai W; Pan HQ; Ouyang B; Greenberg JM; Means RT; Li B; Cardie J
    Leukemia; 1996 Jun; 10(6):978-83. PubMed ID: 8667655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
    Liersch-Löhn B; Slavova N; Buhr HJ; Bennani-Baiti IM
    Int J Cancer; 2016 Mar; 138(5):1220-31. PubMed ID: 26414866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the flt3 receptor and its ligand on hematopoietic cells.
    Brasel K; Escobar S; Anderberg R; de Vries P; Gruss HJ; Lyman SD
    Leukemia; 1995 Jul; 9(7):1212-8. PubMed ID: 7630197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines.
    Dirks WG; Fähnrich S; Lis Y; Becker E; MacLeod RA; Drexler HG
    Int J Cancer; 2002 Jul; 100(1):49-56. PubMed ID: 12115586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and regulation of receptor tyrosine kinases Rse and Mer and their ligand Gas6 in testicular somatic cells.
    Chan MC; Mather JP; McCray G; Lee WM
    J Androl; 2000; 21(2):291-302. PubMed ID: 10714824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of serine threonine tyrosine kinase 1/novel oncogene with kinase domain mRNA in patients with acute leukemia.
    Kondoh T; Kobayashi D; Tsuji N; Kuribayashi K; Watanabe N
    Exp Hematol; 2009 Jul; 37(7):824-30. PubMed ID: 19409952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.